Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan 60 Degrees Pharmaceuticals, Inc. (SXTP)

60 Degrees Pharmaceuticals focuses on malaria therapies for military and traveler needs. This price chart reflects an EV/EBITDA ratio of 0.00. Current revenue is based on Pentagon government contracts, although the growth potential for new drugs is still emerging. Meanwhile, the business possesses immense scalability potential: a single successful drug could generate colossal profits with low production costs.

60 Degrees Pharmaceuticals, Inc. - Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan SXTP (periode 23.11.2025 - 12.11.2026)

Ringkesan rincian data analitis 60degreespharma.com (SXTP)

- rega saiki lan proyeksi nilai saham:

Rega saham 60 Degrees Pharmaceuticals, Inc.|SXTP - Target median analis

- rincian kapitalisasi pasar:

Nilai pasar 60 Degrees Pharmaceuticals, Inc.|SXTP - Nilai Bisnis

- indikator nilai buku ekuitas:

Nilai Buku saben Saham 60 Degrees Pharmaceuticals|SXTP - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku 60degreespharma.com|SXTP - Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Total Utang marang Modal 60 Degrees Pharmaceuticals|SXTP - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas 60 Degrees Pharmaceuticals, Inc.|SXTP - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku 60 Degrees Pharmaceuticals, Inc.|SXTP - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan 60 Degrees Pharmaceuticals|Likuiditas cepet 60degreespharma.com

- rincian asil keuangan lan kelipatan valuasi:

SXTP - Bathi perusahaan|Bathi sing dikarepake 60 Degrees Pharmaceuticals|SXTP - Periode bali modal bisnis|Rasio rega marang bathi sing dikarepake 60 Degrees Pharmaceuticals, Inc.|SXTP - Rasio nilai perusahaan marang wutah bathi|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan 60 Degrees Pharmaceuticals, Inc.|SXTP - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) 60 Degrees Pharmaceuticals|SXTP - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan 60degreespharma.com|SXTP - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep 60 Degrees Pharmaceuticals

Analisis umum perusahaan:60 Degrees Pharma SXTP

Sampel barang 60 Degrees Pharmaceuticals Inc.

This indicator determines the total enterprise value relative to its operating profit before depreciation, taxes, and interest. By analyzing the EV/EBITDA multiple chart, an investor assesses the efficiency of capital management and debt load. For 60 Degrees Pharmaceuticals (SXTP), this metric reflects the capital intensity of developing unique antimalarial drugs, converting regulatory approval into actual market asset value.

Analisis perusahaan pesaing